US · Consumer Cyclical · Specialty Retail
EPS came in at -1.97 against a street estimate of -2.07 — a beat of 4.8%.
Analysts rate RH a buy (10 buy, 8 hold, 2 sell out of 20) with an average price target of $174.00.
| Fund | Stake |
|---|---|
| FMR Inc | 14.77% |
| Alyeska Investment Group, L.P. | 8.65% |
| BlackRock Inc | 7.38% |
| UBS Group AG | 3.76% |
| Vanguard Capital Management, LLC | 3.59% |
| Vanguard Portfolio Management, LLC | 3.46% |
| Point72 Asset Management, L.P. | 3.39% |
| RIMA MANAGEMENT, LLC | 3.36% |
| Document | Date |
|---|---|
| Reg FD disclosure · Q3 2026 | 2026-07-23 |
| Reg FD disclosure · Q3 2026 | 2026-07-08 |
| Shareholder vote results · Q2 2026 | 2026-06-25 |
| Quarterly report · Q2 2026 | 2026-06-11 |
| Results announced · Q2 2026 | 2026-06-11 |
| Proxy statement · Q2 2026 | 2026-05-04 |
| Annual report FY2026 | 2026-04-01 |
| Quarterly report · Q4 2025 | 2025-12-11 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for RH — free to start.
Google PlayApp StoreData updated 2026-08-05.